AstraZeneca strikes $40 million AI drug discovery deal with insitro

3

By Patrick Wingrove LONDON, Oct 15 (Reuters) – AstraZeneca has teamed up with artificial intelligence biotech company insitro to discover and develop new treatments for difficult to treat liver and

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)